Medicare Advantage and Type 2 Diabetes Outcomes
Listen to this summary
The authors aimed to determine whether Medicare Advantage (MA) coverage leads to better outcomes for individuals with type 2 diabetes (T2D) compared to Original Medicare (OM). Their longitudinal cohort study found no significant differences in key health metrics such as HbA1c, blood pressure, and LDL cholesterol, nor in social determinants of health like food insecurity and housing instability, between the two groups after 12 months. This raises concerns about the effectiveness of the higher spending associated with MA in improving health outcomes for T2D patients.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from JAMA internal medicine
View all →Sep 21, 2026 · JAMA internal medicine
Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma
Sep 14, 2026 · JAMA internal medicine
Effective Palliative Care for Hospice Transitions
Sep 8, 2026 · JAMA internal medicine
Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor Symptoms
Sep 8, 2026 · JAMA internal medicine
Timing of Initiation of Methadone Take-Home Dosing
Aug 31, 2026 · JAMA internal medicine
Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes
Aug 30, 2026 · JAMA internal medicine
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


